The use of radioactive iodine (RAI) for patients with thyroid cancer (TC) who are also treated with hemodialysis for end-stage renal disease (HD-ESRD) remains challenging, with several issues still ...
Journal of Nuclear Medicine April 2026, jnumed.126.272026; DOI: https://doi.org/10.2967/jnumed.126.272026 As radiopharmaceutical therapy (RPT) expands beyond ...
Journal of Nuclear Medicine May 2026, jnumed.125.271348; DOI: https://doi.org/10.2967/jnumed.125.271348 ...
This paper presents a systematic analysis of the inherent uncertainty in internal dose calculations for radiopharmaceuticals. A generic equation for internal dose is presented, and the uncertainty in ...
Objectives The OLINDA/EXM code developed by the RAdiation Dose Assessment Resource (RADAR) Task Group of the Society of Nuclear Medicine has standardized dose calculations for diagnostic and ...
Figure][1] Katherine W. Ferrara, PhD Dr. Katherine W. Ferrara is a professor of radiology at Stanford University and the division chief for the Molecular Imaging Program at Stanford (MIPS). Before her ...
Journal of Nuclear Medicine April 2026, jnumed.125.271880; DOI: https://doi.org/10.2967/jnumed.125.271880 ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Sui Wai Ling, Mark Konijnenberg, Marcel Segbers, Eline Hooijman, Stijn Koolen, Erik de Blois, Linda C. De Jong, Andrea van Puffelen, Quido de Lussanet de la Sabloniere, Frank Bruchertseifer, Elena ...
Phase 2 Prospective Trial of Retreatment with [177 Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer—RE-LuPSMA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results